BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/10/2014 7:09:00 PM | Browse: 650 | Download: 662
Publication Name World Journal of Gastroenterology
Manuscript ID 7539
Country of Manuscript Source United States
Received
2013-11-24 10:23
Peer-Review Started
2013-11-24 15:27
To Make the First Decision
2013-12-26 10:58
Return for Revision
2013-12-27 20:57
Revised
2014-05-31 22:24
Second Decision
2014-06-26 17:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-26 17:26
Articles in Press
2014-06-26 17:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-21 16:35
Publish the Manuscript Online
2014-11-10 19:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Retrospective Study
Article Title Hepatitis B vaccination in patients with inflammatory bowel disease
Manuscript Source Invited Manuscript
All Author List Ruwaida Ben Musa, Anuhya Gampa, Sanjib Basu, Ali Keshavarzian, Garth Swanson, Michael Brown, Rana Abraham, Keith Bruninga, John Losurdo, Mark DeMeo, Sohrab Mobarhan, David Shapiro and Ece Mutlu
Funding Agency and Grant Number
Corresponding author Ece Mutlu, MD, MS, MBA, Associate Professor, IBD Program Director, Department of Medicine, Clinical Research Section of Gastroenterology, Hepatology and Nutrition, Rush University, 1725 W. Harrison, Suite 206, Chicago, IL 60612, United States. ece_mutlu@rush.edu
Keywords Inflammatory bowel disease; Hepatitis B; Prevalence; Vaccination; Ulcerative colitis; Crohn’s disease
Core Tip With immunomodulatory drugs being used for treatment of inflammatory bowel disease (IBD) patients, it is important that IBD patients be protected against preventable infections, specifically hepatitis B. Compared to previous literature, the prevalence of hepatitis B virus (HBV) in IBD patients in a large tertiary gastroenterology practice in the United States was not higher than Europe. However, a significant portion of IBD patients were not routinely screened and vaccinated against HBV at a large tertiary gastroenterology practice. This corroborates the need for gastroenterologists and primary care physicians to be cognizant of treating IBD patients for preventable diseases in addition to managing IBD itself. Further education and use of electronic record prompters may be needed to increase prevention of HBV.
Publish Date 2014-11-10 19:10
Citation Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(41): 15358-15366
Url http://www.wjgnet.com/1007-9327/full/v20/i41/15358.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i41.15358
Full Article (PDF) WJG-20-15358.pdf
Full Article (Word) WJG-20-15358.doc
Manuscript File 7539-Review.docx
Answering Reviewers 7539-Answering reviewers.pdf
Biostatistics Review Certificate Biostatistician_Review_Report_20131123074743.pdf
Copyright License Agreement 7539-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethics_Committee_20131123074705.pdf
Peer-review Report 7539-Peer review.pdf
Scientific Misconduct Check 7539-CorssCheck.jpg
Scientific Editor Work List 7539-Scientific editor work list.pdf